Loading…
Reported covered position: Chief of Staff, Rep. Hilda L. Solis (Jan 2005-Oct 2008) Legislative Counsel/Asst, Rep. Hilda L. Solis (Mar 2002-Dec 2004)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2026 · third_quarter · Q3
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
Source: Senate LDA
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
PAAT Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
PAAT Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Consolidated Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R.7148 - Consolidated Appropriations Act, 2026
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
Military Next-Gen Collision Avoidance Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Military Next-Gen Collision Avoidance Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Relief of Chronic Pain Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 1 - One Big Beautiful Bill H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, FY 2026 Issues pertaining to NIH research funding
Medical Device Electronic Labeling Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues pertaining to NIH research funding H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025
Expanding Access to Diabetes Self-Management Training Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 1 - One Big Beautiful Bill H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, FY 2026 Issues pertaining to NIH research funding
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
PAAT Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Special Diabetes Program for Indians Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Special Diabetes Program for Indians Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Charitable Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 317 / H.R. 801, The Charitable Act
Chronic Disease Flexible Coverage Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act
Expanding Access to Diabetes Self-Management Training Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Charitable Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 317 / H.R. 801, The Charitable Act
American Relief Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10545 - American Relief Act of 2025. H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10545 - American Relief Act of 2025. H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Government Surveillance Reform Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2026 · second_quarter · Q2
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2026 · first_quarter · Q1
H.R.7148 - Consolidated Appropriations Act, 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · fourth_quarter · Q4
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · third_quarter · Q3
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · second_quarter · Q2
H.R. 1 - One Big Beautiful Bill H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, FY 2026 Issues pertaining to NIH research funding
Issues pertaining to NIH research Issues pertaining to Medicare coverage of AID and CGM systems Issues pertaining to pre-deductible coverage of chronic disease treatments in high-deductible health plans
S. 317 / H.R. 801, The Charitable Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · first_quarter · Q1
Issues pertaining to NIH research funding H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025
Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · fourth_quarter · Q4
H.R. 10545 - American Relief Act of 2025. H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE